ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $544,572 | +22.9% | 25,200 | +10.0% | 0.00% | – |
| Q3 2022 | $443,000 | -2.6% | 22,900 | 0.0% | 0.00% | – |
| Q2 2022 | $455,000 | -33.4% | 22,900 | 0.0% | 0.00% | – |
| Q1 2022 | $683,000 | +28.6% | 22,900 | +0.4% | 0.00% | – |
| Q4 2021 | $531,000 | -25.3% | 22,800 | 0.0% | 0.00% | – |
| Q3 2021 | $711,000 | -11.3% | 22,800 | 0.0% | 0.00% | – |
| Q2 2021 | $802,000 | +9.4% | 22,800 | +9.6% | 0.00% | – |
| Q1 2021 | $733,000 | -6.0% | 20,800 | 0.0% | 0.00% | – |
| Q4 2020 | $780,000 | +3.4% | 20,800 | -8.0% | 0.00% | – |
| Q3 2020 | $754,000 | +84.8% | 22,600 | +46.8% | 0.00% | – |
| Q2 2020 | $408,000 | +120.5% | 15,400 | +36.3% | 0.00% | – |
| Q1 2020 | $185,000 | -10.2% | 11,300 | +76.6% | 0.00% | – |
| Q2 2019 | $206,000 | – | 6,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |